ATAC DDC Liaison: Bob Huff
CONTACT INFORMATION
Community Contacts:
Eastern US: (East of Detroit)
Jim Howley
Manager, National Advocacy Relations
352-384-0603
[email protected]
PRODUCT INFORMATION
- FDA-Approved Products:
- HIV protease inhibitors: Ritonavir (Norvir®), Lopinavir (Kaletra®)
- Products in Development: Discovery efforts ongoing; none in clinical trials
Web page: Abbott HIV Infection & AIDS http://www.rxabbott.com/hiv/hiv0044.htm ; Kaletra at http://www.kaletra.com
KEY PERSONNEL (Working in HIV, HBV, and HCV)
- Jodi Devlin, Vice President, Antiviral Franchise
- Bill Calhoun, Director, Pharmaceutical Alliances 847-938-6411 (Business development and activities with partner companies an key customer groups)
- Nicole Wesley, Manager, Pharmaceutical Public Affairs Telephone: 847-935-9877
- PRODUCT PLANNING AND DEVELOPMENT
- Dr. Michael Fath, Senior Manager, Global New Product Planning
- Dr. Eugene Sun, Vice President, Antiviral Clinical Development
- Dr. Dale Kempf, Senior Scientist, Antiviral Product Discovery
- MARKETING AND SALES
- Rosemarie Waleska, Director, HIV Marketing Unit
- Julie Fitzgerald, Senior Product Manager, HIV Products
- Isabelle Gaultier, Senior Manager, Antiviral/Abbott International (Hepatitis C)
|